Price T Rowe Associates Inc Axogen, Inc. Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 34,820 shares of AXGN stock, worth $650,437. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,820
Previous 31,600
10.19%
Holding current value
$650,437
Previous $444,000
29.28%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AXGN
# of Institutions
179Shares Held
36.2MCall Options Held
82.6KPut Options Held
1.1K-
First Light Asset Management, LLC Edina, MN4.51MShares$84.2 Million7.26% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$60.7 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.96MShares$55.2 Million3.39% of portfolio
-
Morgan Stanley New York, NY2.43MShares$45.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$45.3 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $790M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...